Marie Brachet-Botineau - Search Results

Year	Number of Results
2017	2
2018	2
2019	1
2020	3
2021	4
2024	0

1

Dibenzofuran Derivatives Inspired from Cercosporamide as Dual Inhibitors of Pim and CLK1 Kinases.

Dao VH, Ourliac-Garnier I, Logé C, McCarthy FO, Bach S, da Silva TG, Denevault-Sabourin C, Thiéfaine J, Baratte B, Robert T, Gouilleux F, Brachet-Botineau M, Bazin MA, Marchand P. Dao VH, et al. Among authors: brachet botineau m. Molecules. 2021 Oct 30;26(21):6572. doi: 10.3390/molecules26216572. Molecules. 2021. PMID: 34770981 Free PMC article.

2

Design, synthesis, and antiproliferative effect of 2,9-bis[4-(pyridinylalkylaminomethyl)phenyl]-1,10-phenanthroline derivatives on human leukemic cells by targeting G-quadruplex.

Guillon J, Denevault-Sabourin C, Chevret E, Brachet-Botineau M, Milano V, Guédin-Beaurepaire A, Moreau S, Ronga L, Savrimoutou S, Rubio S, Ferrer J, Lamarche J, Mergny JL, Viaud-Massuard MC, Ranz M, Largy E, Gabelica V, Rosu F, Gouilleux F, Desplat V. Guillon J, et al. Among authors: brachet botineau m. Arch Pharm (Weinheim). 2021 Aug;354(8):e2000450. doi: 10.1002/ardp.202000450. Epub 2021 Apr 14. Arch Pharm (Weinheim). 2021. PMID: 33852185

3

New Quinoxaline Derivatives as Dual Pim-1/2 Kinase Inhibitors: Design, Synthesis and Biological Evaluation.

Oyallon B, Brachet-Botineau M, Logé C, Robert T, Bach S, Ibrahim S, Raoul W, Croix C, Berthelot P, Guillon J, Pinaud N, Gouilleux F, Viaud-Massuard MC, Denevault-Sabourin C. Oyallon B, et al. Among authors: brachet botineau m. Molecules. 2021 Feb 6;26(4):867. doi: 10.3390/molecules26040867. Molecules. 2021. PMID: 33562106 Free PMC article.

4

Inhibitors Targeting STAT5 Signaling in Myeloid Leukemias: New Tetrahydroquinoline Derivatives with Improved Antileukemic Potential.

Polomski M, Brachet-Botineau M, Juen L, Viaud-Massuard MC, Gouilleux F, Prié G. Polomski M, et al. Among authors: brachet botineau m. ChemMedChem. 2021 Mar 18;16(6):1034-1046. doi: 10.1002/cmdc.202000841. Epub 2021 Jan 20. ChemMedChem. 2021. PMID: 33275308

5

Acriflavine targets oncogenic STAT5 signaling in myeloid leukemia cells.

Hallal R, Nehme R, Brachet-Botineau M, Nehme A, Dakik H, Deynoux M, Dello Sbarba P, Levern Y, Zibara K, Gouilleux F, Mazurier F. Hallal R, et al. Among authors: brachet botineau m. J Cell Mol Med. 2020 Sep;24(17):10052-10062. doi: 10.1111/jcmm.15612. Epub 2020 Jul 15. J Cell Mol Med. 2020. PMID: 32667731 Free PMC article.

6

History, extensive characterization and challenge of anti-tetanus serum from World War I: exciting remnants and deceived hopes : Centenarian IgGs lost their neutralization capacity.

Aubert N, Brachet-Botineau M, de Olivera Preto GE, Benz-de Bretagne I, Watier H, Brachet G. Aubert N, et al. Among authors: brachet botineau m. Immunol Res. 2020 Feb;68(1):7-12. doi: 10.1007/s12026-020-09121-z. Immunol Res. 2020. PMID: 32144721

7

Pharmacological Inhibition of Oncogenic STAT3 and STAT5 Signaling in Hematopoietic Cancers.

Brachet-Botineau M, Polomski M, Neubauer HA, Juen L, Hédou D, Viaud-Massuard MC, Prié G, Gouilleux F. Brachet-Botineau M, et al. Cancers (Basel). 2020 Jan 18;12(1):240. doi: 10.3390/cancers12010240. Cancers (Basel). 2020. PMID: 31963765 Free PMC article. Review.

8

A Novel Inhibitor of STAT5 Signaling Overcomes Chemotherapy Resistance in Myeloid Leukemia Cells.

Brachet-Botineau M, Deynoux M, Vallet N, Polomski M, Juen L, Hérault O, Mazurier F, Viaud-Massuard MC, Prié G, Gouilleux F. Brachet-Botineau M, et al. Cancers (Basel). 2019 Dec 17;11(12):2043. doi: 10.3390/cancers11122043. Cancers (Basel). 2019. PMID: 31861239 Free PMC article.

9

Structure-based design of novel quinoxaline-2-carboxylic acids and analogues as Pim-1 inhibitors.

Oyallon B, Brachet-Botineau M, Logé C, Bonnet P, Souab M, Robert T, Ruchaud S, Bach S, Berthelot P, Gouilleux F, Viaud-Massuard MC, Denevault-Sabourin C. Oyallon B, et al. Among authors: brachet botineau m. Eur J Med Chem. 2018 Jun 25;154:101-109. doi: 10.1016/j.ejmech.2018.04.056. Epub 2018 May 11. Eur J Med Chem. 2018. PMID: 29778892

10

Impact of cathepsin B-sensitive triggers and hydrophilic linkers on in vitro efficacy of novel site-specific antibody-drug conjugates.

Bryden F, Martin C, Letast S, Lles E, Viéitez-Villemin I, Rousseau A, Colas C, Brachet-Botineau M, Allard-Vannier E, Larbouret C, Viaud-Massuard MC, Joubert N. Bryden F, et al. Among authors: brachet botineau m. Org Biomol Chem. 2018 Mar 14;16(11):1882-1889. doi: 10.1039/c7ob02780j. Org Biomol Chem. 2018. PMID: 29473076

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

12 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year